A Federal judge in New York today granted Amarin Pharma’s request for an injunction against the enforcement by the U.S. Food & Drug Administration of rules that would otherwise prohibit the communication to physicians of truthful information about unapproved uses of its product Vascepa® (isocapent ethyl). Today’s ruling follows the 2012 opinion [...]